The progress in the therapy of chronic myeloid leukemia
Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 6
Abstract
The review describes current standards of chronic myeloid leukemia (CML) treatment. Recommendation of European LeukemiaNET for CML treatment are presented. In most patients as a first line treatment in newly diagnosed CML , imatinib since several years is the treatment of choice. Recommendation of second line treatment in case treatment failure are presented. In These cases second generation of tyrosine kinase inhibitors – dasatinib and nilotinib are the most preferred drugs. Indications for allogenic bone marrow transplantation for the resistant patients are also presented. Besides, new trends – which are at the stage of clinical trials aimed to cure the disease are presented.
Authors and Affiliations
Witold Prejzner, Andrzej Hellmann
Keywords
Related Articles
- EP ID EP54201
- DOI -
- Views 122
- Downloads 0
Diagnostic imaging in contemporary oncology
Diagnostic imaging has an important role in all stages of management of oncologic patients and its proper application leads not only to improved treatment results, but also to increased cost-effectiveness.The great numbe...
Prophylaxis and treatment of hyperhomocysteinemia
Homocysteine (Hcys) is a non-protein sulfur-containing amino acid, an intermediate product of methionine metabolism. It is known that elevated concentration of homocysteine (> 15 µM; hyperhomocysteinemia) in human...
The alterations of non-specific and specific cellular immunity in acute pancreatitis
Acute pancreatitis represents a local inflammatory disorder with severe systemic consequences. Multiple organ failure and sepsis in the late phase contribute to the high mortality of severe acute pancreatitis. In order t...
Buschke-Loewenstein tumor – a difficult interdisciplinary problem
Giant condylomaacuminatum (also known as a Buschke-Lowenstein tumor and giant condyloma of Buschke-Lowenstein tumor) is a disease caused by an infection with HPV type 6 and 11, rarely 16, 18, 54 and according to the WHO,...
Management of pain in rheumatic diseases
Chronic pain is one of main symptoms of majority of rheumatic diseases. Because more than seventy percent of population over fifty year-old suffer of rheumatic disorders, so they are most often reason of chronic pain syn...